Free Trial

Trevi Therapeutics (TRVI) Institutional Ownership

Trevi Therapeutics logo
$2.77 -0.23 (-7.67%)
(As of 11/20/2024 ET)

Institutional Ownership Changes (13F Filings) for Trevi Therapeutics (NASDAQ:TRVI)

Current
Institutional Ownership
Percentage
95.76%
Number of
Institutional Buyers
(last 12 months)
25
Total
Institutional Inflows
(last 12 months)
$13.69M
Number of
Institutional Sellers
(last 12 months)
11
Total
Institutional Outflows
(last 12 months)
$10.05M
Get TRVI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Trevi Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

TRVI Institutional Buying and Selling by Quarter

Trevi Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024 Barclays PLC95,232$319K0.0%+180.8%0.124%
11/16/2024 Geode Capital Management LLC1,264,166$4.22M0.0%+10.2%1.645%
11/15/2024 Barclays PLC95,232$319K0.0%+180.8%0.124%
11/15/2024 Jane Street Group LLC32,929$110K0.0%-50.4%0.043%
11/15/2024 State Street Corp952,912$3.18M0.0%+5.9%1.240%
11/15/2024 Checkpoint Capital L.P.250,000$835K0.4%-50.0%0.325%
11/14/2024 Fred Alger Management LLC76,544$256K0.0%N/A0.100%
11/14/2024 Ally Bridge Group NY LLC1,322,800$4.42M2.4%-10.3%1.721%
11/14/2024 Acuta Capital Partners LLC290,500$970K0.8%+11.7%0.378%
11/13/2024 BNP Paribas Financial Markets11,930$40K0.0%+130.9%0.016%
11/9/2024 Landscape Capital Management L.L.C.424,725$1.42M0.1%-29.8%0.585%
11/9/2024 Intech Investment Management LLC18,914$63K0.0%N/A0.026%
11/7/2024 MAI Capital Management1,327,285$4.43M0.0%+0.7%1.828%
11/6/2024 Oppenheimer & Co. Inc.81,947$274K0.0%+34.7%0.113%
11/5/2024 GSA Capital Partners LLP122,447$409K0.0%N/A0.169%
10/30/2024 Rosalind Advisors Inc.750,000$2.51M1.6%-46.1%1.033%
10/3/2024 SG Americas Securities LLC23,405$78K0.0%N/A0.033%
8/15/2024 The Manufacturers Life Insurance Company24,524$73K0.0%+87.6%0.035%
8/14/2024 Logos Global Management LP2,800,000$8.34M0.7%+27.3%3.975%
8/14/2024 Ally Bridge Group NY LLC1,474,926$4.40M2.6%N/A2.094%
8/13/2024 Rubric Capital Management LP5,026,931$14.98M0.4%-9.7%7.137%
8/12/2024 Hsbc Holdings PLC19,612$61K0.0%N/A0.028%
8/9/2024 Renaissance Technologies LLC51,900$155K0.0%-55.6%0.074%
8/9/2024 Dimensional Fund Advisors LP72,210$215K0.0%+217.6%0.103%
8/8/2024 American Century Companies Inc.54,108$161K0.0%+17.1%0.077%
8/1/2024 Rhumbline Advisers75,218$224K0.0%+44.8%0.107%
7/26/2024 Bank of New York Mellon Corp178,511$532K0.0%+38.8%0.253%
7/12/2024 Rosalind Advisors Inc.1,391,577$4.15M3.0%+50.3%1.976%
5/29/2024 Opaleye Management Inc.2,645,000$9.13M2.0%+4.3%3.756%
5/15/2024 Price T Rowe Associates Inc. MD13,561$47K0.0%N/A0.019%
5/14/2024 Propel Bio Management LLC260,000$897K0.5%N/A0.369%
5/10/2024 Vanguard Group Inc.2,303,648$7.95M0.0%+2.7%3.271%
5/7/2024 Oppenheimer & Co. Inc.60,415$208K0.0%N/A0.086%
5/7/2024 SG Americas Securities LLC14,592$50K0.0%-85.1%0.021%
5/1/2024 BNP Paribas Financial Markets20,577$71K0.0%-84.4%0.030%
4/25/2024 Rosalind Advisors Inc.926,016$3.20M3.0%-50.3%1.343%
2/15/2024 Opaleye Management Inc.2,535,000$3.40M0.9%+48.6%3.970%
2/15/2024 Frazier Life Sciences Management L.P.7,381,090$9.89M0.5%+7.3%11.559%
2/5/2024 WealthTrust Axiom LLC63,500$85K0.0%-32.1%0.099%
1/12/2024 SG Americas Securities LLC98,253$132K0.0%+401.4%0.154%
Trump said you could learn something from this man (Ad)

Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.

Here’s everything you need to know.
1/4/2024 Trust Co. of Toledo NA OH36,502$49K0.0%-68.8%0.057%
11/13/2023 Silverarc Capital Management LLC927,415$2.02M0.6%+4.7%1.452%
10/20/2023 Trust Co. of Toledo NA OH117,145$255K0.1%-6.2%0.183%
10/13/2023 SG Americas Securities LLC19,597$43K0.0%N/A0.031%
9/21/2023 Barclays PLC14,052$34K0.0%N/A0.022%
8/11/2023 VR Adviser LLC3,422,397$8.18M1.3%+12.2%5.697%
8/11/2023 Tejara Capital Ltd180,227$431K0.2%-5.3%0.300%
8/4/2023 American International Group Inc.20,037$48K0.0%N/A0.033%
8/3/2023Innovis Asset Management LLC43,232$103K0.0%-50.5%0.072%
8/2/2023 MAI Capital Management1,534,652$3.67M0.1%-4.1%2.555%
7/10/2023 Trust Co. of Toledo NA OH124,857$298K0.1%+50.4%0.208%
5/12/2023 Tejara Capital Ltd190,218$352K0.2%+26.8%0.317%
5/10/2023 MAI Capital Management1,600,415$2.96M0.0%-7.0%2.664%
4/4/2023 Trust Co. of Toledo NA OH83,000$154K0.0%N/A0.138%
2/10/2023 Opaleye Management Inc.485,000$936K0.3%N/A0.809%
2/9/2023 MAI Capital Management1,720,676$3.32M0.1%-14.8%2.872%
2/3/2023 Frazier Life Sciences Management L.P.6,663,590$12.86M0.8%+23.3%11.121%
2/2/2023 Bailard Inc.21,200$41K0.0%N/A0.035%
2/1/2023 Bank of Montreal Can152,300$294K0.0%N/A0.254%
11/15/2022 TPG GP A LLC251,780$388K0.0%-94.2%0.571%
11/14/2022 Armistice Capital LLC864,000$1.33M0.0%+107.7%1.961%
11/14/2022 Altium Capital Management LP1,066,157$1.64M0.6%-17.0%2.419%
11/14/2022 Rubric Capital Management LP5,684,420$8.75M0.4%+219.6%12.899%
11/10/2022 Hillsdale Investment Management Inc.86,531$133K0.0%N/A0.196%
11/9/2022 Fairmount Funds Management LLC5,696,515$8.77M1.5%+250.7%12.926%
11/7/2022 Jump Financial LLC42,977$66K0.0%N/A0.098%
10/28/2022 Silverarc Capital Management LLC939,265$1.45M0.5%N/A2.131%
8/15/2022 Acuta Capital Partners LLC35,000$98K0.1%N/A0.090%
8/10/2022 Frazier Life Sciences Management L.P.1,171,627$3.29M0.3%N/A3.029%
7/27/2022 WealthTrust Axiom LLC93,500$262K0.1%-5.1%0.242%
7/19/2022 MAI Capital Management2,040,009$5.73M0.1%+32.3%5.273%
5/10/2022 MAI Capital Management1,541,471$3.39M0.1%N/A3.985%
5/9/2022 WealthTrust Axiom LLC98,500$216K0.1%+245.6%0.255%
5/4/2022Commonwealth Equity Services LLC15,000$33K0.0%N/A0.049%
8/17/2021 Bridgeway Capital Management LLC34,600$78K0.0%-68.4%0.160%
8/16/2021 Alberta Investment Management Corp25,000$56K0.0%N/A0.116%
8/13/2021 Renaissance Technologies LLC92,600$208K0.0%-24.0%0.429%
5/21/2021 Citadel Advisors LLC10,617$29K0.0%N/A0.053%
5/18/2021 Citadel Advisors LLC10,617$29K0.0%N/A0.053%
5/13/2021 Renaissance Technologies LLC121,849$330K0.0%+374.1%0.611%
5/7/2021BlackRock Inc.32,394$87K0.0%+40.6%0.163%
4/14/2021 WealthTrust Axiom LLC38,500$104K0.0%+234.8%0.193%
3/26/2021 Susquehanna International Group LLP14,828$36K0.0%N/A0.081%
2/17/2021 Canada Pension Plan Investment Board15,000$36K0.0%N/A0.082%
2/10/2021 Renaissance Technologies LLC25,700$62K0.0%N/A0.140%
2/4/2021 WealthTrust Axiom LLC11,500$27K0.0%N/A0.063%
(Data available from 1/1/2016 forward)

TRVI Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of TRVI shares?

During the previous two years, 39 institutional investors and hedge funds held shares of Trevi Therapeutics. The most heavily invested institutionals were Rubric Capital Management LP ($14.98M), Frazier Life Sciences Management L.P. ($9.89M), Opaleye Management Inc. ($9.13M), Logos Global Management LP ($8.34M), VR Adviser LLC ($8.18M), Vanguard Group Inc. ($7.95M), and MAI Capital Management ($4.43M).Learn more on TRVI's institutional investors.

What percentage of Trevi Therapeutics stock is owned by institutional investors?

95.76% of Trevi Therapeutics stock is owned by institutional investors. Learn more on TRVI's institutional investor holdings.

Which institutional investors have been buying Trevi Therapeutics stock?

Of the 32 institutional investors that purchased Trevi Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Frazier Life Sciences Management L.P. ($1.76M), Ally Bridge Group NY LLC ($1.47M), Opaleye Management Inc. ($1.42M), Logos Global Management LP ($600K), Rosalind Advisors Inc. ($465.56K), VR Adviser LLC ($372.38K), and Propel Bio Management LLC ($260K).

How much institutional buying is happening at Trevi Therapeutics?

Institutional investors have bought a total of 7,766,817 shares in the last 24 months. This purchase volume represents approximately $18.82M in transactions.

Which Trevi Therapeutics major shareholders have been selling company stock?

Of the 14 institutional investors that sold Trevi Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Rosalind Advisors Inc. ($1.58M), Rubric Capital Management LP ($537.19K), MAI Capital Management ($484.51K), Checkpoint Capital L.P. ($250.09K), Landscape Capital Management L.L.C. ($180.72K), Ally Bridge Group NY LLC ($152.13K), and BNP Paribas Financial Markets ($111.63K).

How much institutional selling is happening at Trevi Therapeutics?

Institutional investors have sold a total of 3,648,779 shares in the last 24 months. This volume of shares sold represents approximately $11.15M in transactions.



This page (NASDAQ:TRVI) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners